Target intelligence / Profile preview

Mycobacterial energy metabolism components

Molecular classification
Enzyme, Multi-protein complex, Transporter
01

Overview

Mycobacterial energy metabolism components refer to the specialized machinery used by Mycobacterium tuberculosis to generate cellular energy through oxidative phosphorylation. This system includes essential enzymes such as ATP synthase, the cytochrome bc1-aa3 oxidase complex, and various dehydrogenases that maintain the electrochemical gradient across the bacterial membrane (Cook et al., 2014, PubMed: 25157167). Unlike many other pathogens, M. tuberculosis is an obligate aerobe that depends heavily on these respiratory chain components for survival during both active infection and latent persistence (Bald et al., 2017, PubMed: 28348141). Therapeutic intervention in this pathway has been highly successful, exemplified by the approval of bedaquiline, which binds to the c-subunit of ATP synthase to halt ATP production (Andries et al., 2005, PubMed: 15647434). Other clinical candidates like telacebec target the QcrB subunit of the cytochrome bc1 complex, effectively blocking electron transport and reducing cellular ATP levels (Pethe et al., 2013, PubMed: 23913023). Because these metabolic pathways are distinct from human mitochondrial respiration in specific structural ways, they offer a high degree of selectivity for treating tuberculosis, including drug-resistant strains. However, challenges remain regarding the potential for cardiotoxicity, such as QT interval prolongation, and the need for long-term treatment regimens to ensure complete eradication of dormant bacilli.

Other names
Mycobacterial respiratory chainMycobacterial oxidative phosphorylation systemMtb energy metabolismMycobacterial electron transport chain
02

Mechanism of action

Inhibition of ATP synthase (AtpE subunit), inhibition of the cytochrome bc1-aa3 oxidase complex (QcrB subunit), and disruption of the respiratory electron transport chain or proton motive force (Cook et al., 2014, PubMed: 25157167).

03

Biological functions

Cellular respirationATP synthesisProton motive force maintenanceEnergy homeostasis
04

Disease associations

InfectionTuberculosis
05

Safety considerations

QT interval prolongationHepatotoxicityIncreased mortality riskDrug-drug interactions via CYP3A4Emergence of drug resistance
06

Interacting drugs

Bedaquiline

3 more in the full profile.

07

Biomarkers

Sputum culture conversionTime to Positivity (TTP) in liquid cultureMycobacterial DNA loadSerum bedaquiline concentrationsLipoarabinomannan (LAM) levels

Beyond the preview

Go deeper on Mycobacterial energy metabolism components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial energy metabolism components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call